...
首页> 外文期刊>Journal of Materials Chemistry: An Interdisciplinary Journal dealing with Synthesis, Structures, Properties and Applications of Materials, Particulary Those Associated with Advanced Technology >Ligand exchange triggered controlled-release targeted drug delivery system based on core-shell superparamagnetic mesoporous microspheres capped with nanoparticles
【24h】

Ligand exchange triggered controlled-release targeted drug delivery system based on core-shell superparamagnetic mesoporous microspheres capped with nanoparticles

机译:基于核-壳超顺磁介孔微球包覆纳米粒子的配体交换触发控释靶向药物递送系统

获取原文
获取原文并翻译 | 示例

摘要

We report a new controlled-release targeted drug delivery system based on core-shell structured silica mesoporous microspheres capped with superparamagnetic iron oxide nanoparticles. A ligand exchange strategy was developed to release guest molecules loaded in the mesopores. The system possesses a stimuli-responsive release property for the entrapped guest molecules, which is important for the delivery of toxic anticancer drugs in chemotherapy. A variety of stimulating agents, such as EDTA and sodium citrate, have been used to release the entrapped guest molecules, relying on the new ligand exchange triggered release mechanism. The release rate of guest molecules can be controlled by using different trigger-agents. The drug delivery system possesses high saturation magnetization (~58 emu g~(-1)) and superparamagnetic character, and thus can be easily enriched by a permanent magnet and re-dispersed in PBS solutions, which greatly facilitates its manipulation in practical applications. Cytotoxicity analyses of the drug delivery system based on human gastric cancer SGC-7901 and rat pheochromocytoma PC12 cells show low cytotoxicity and good biocompatibility. The uptake properties of the system by SGC-7901 and human cervical carcinoma HeLa cells demonstrate their great potential for applications in drug delivery. Furthermore, in vitro experiments show that cancer cells can be effectively killed by anticancer drug (paclitaxel) released from the system, further indicating the promise of the controlled-release drug delivery system in cancer treatment.
机译:我们报告了基于超顺磁性氧化铁纳米粒子封盖的核壳结构二氧化硅介孔微球的新型控释靶向药物递送系统。开发了配体交换策略以释放加载在中孔中的客体分子。该系统具有对被捕获的客体分子的刺激响应释放特性,这对于化学疗法中有毒抗癌药物的输送非常重要。依靠新的配体交换触发的释放机制,已使用各种刺激剂(如EDTA和柠檬酸钠)释放被困的客体分子。客体分子的释放速率可以通过使用不同的触发剂来控制。该药物递送系统具有高饱和磁化强度(〜58 emu g〜(-1))和超顺磁特性,因此可以容易地被永磁体富集并重新分散在PBS溶液中,极大地方便了其在实际应用中的操作。基于人胃癌SGC-7901和大鼠嗜铬细胞瘤PC12细胞的药物递送系统的细胞毒性分析显示出低细胞毒性和良好的生物相容性。 SGC-7901和人宫颈癌HeLa细胞对系统的吸收特性证明了其在药物递送中的巨大潜力。此外,体外实验表明,癌细胞可以被系统释放的抗癌药物(紫杉醇)有效杀死,这进一步表明了控释给药系统在癌症治疗中的前景。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号